AKEBIA THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

27 5月 2025 08:45:01 条件 NetDania Notify

Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025

27 5月 2025 05:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 5月 2025 06:49:24 条件 NetDania Notify

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

13 5月 2025 05:00:01 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

08 5月 2025 06:59:17 条件 NetDania Notify

Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

08 5月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 5月 2025 13:15:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights

01 5月 2025 05:00:01 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa

03 4月 2025 05:00:01 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 4月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025

25 3月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Announces Pricing of Public Offering of Common Stock

19 3月 2025 19:17:53 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Announces Proposed Public Offering of Common Stock

19 3月 2025 13:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

19 3月 2025 07:01:40 条件 NetDania Notify

NetDania - New 12 months High: AKEBIA THERAPEUTICS INC. - COMMON STOCK

18 3月 2025 10:14:28 条件 NetDania Notify

Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update

13 3月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights

06 3月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 3月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 2月 2025 13:05:00 条件 Nasdaq GlobeNewswire